Increasing treatment rates with co-created patient engagement
Challenge
Evaluating the effectiveness of using digital interventions to increase flu vaccination rates among individuals with type 2 diabetes—a demographic at high risk for flu complications, yet comparatively low vaccination rates.
Approach
We rapidly recruited over 10,400 Evidation community members to a digital program providing vaccination education; ~50% were individuals with self-reported type 1 or 2 diabetes.
Over six months, we engaged participants through ads, educational content, incentives, surveys, and calls to action. As part of the message testing, different participant segments received a mix of content that promoted flu vaccinations more generally and content that focused on diabetes and the flu (e.g., risks specific to diabetes management), while some participants received no flu content at all.
We measured which engagement strategies most effectively drove individuals to get vaccinated. Follow-up surveys were sent to participants to identify those who reported vaccinations.
Results
Up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging.
Identified messages, content, and other tactics that most effectively drive high-risk individuals to schedule vaccinations.
The pharmaceutical team received data-driven insights to expand vaccination programs on a larger scale.
Increasing treatment rates with co-created patient engagement
Challenge
Evaluating the effectiveness of using digital interventions to increase flu vaccination rates among individuals with type 2 diabetes—a demographic at high risk for flu complications, yet comparatively low vaccination rates.
Approach
We rapidly recruited over 10,400 Evidation community members to a digital program providing vaccination education; ~50% were individuals with self-reported type 1 or 2 diabetes.
Over six months, we engaged participants through ads, educational content, incentives, surveys, and calls to action. As part of the message testing, different participant segments received a mix of content that promoted flu vaccinations more generally and content that focused on diabetes and the flu (e.g., risks specific to diabetes management), while some participants received no flu content at all.
We measured which engagement strategies most effectively drove individuals to get vaccinated. Follow-up surveys were sent to participants to identify those who reported vaccinations.
Results
Up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging.
Identified messages, content, and other tactics that most effectively drive high-risk individuals to schedule vaccinations.
The pharmaceutical team received data-driven insights to expand vaccination programs on a larger scale.
Increasing treatment rates with co-created patient engagement
Challenge
Evaluating the effectiveness of using digital interventions to increase flu vaccination rates among individuals with type 2 diabetes—a demographic at high risk for flu complications, yet comparatively low vaccination rates.
Approach
We rapidly recruited over 10,400 Evidation community members to a digital program providing vaccination education; ~50% were individuals with self-reported type 1 or 2 diabetes.
Over six months, we engaged participants through ads, educational content, incentives, surveys, and calls to action. As part of the message testing, different participant segments received a mix of content that promoted flu vaccinations more generally and content that focused on diabetes and the flu (e.g., risks specific to diabetes management), while some participants received no flu content at all.
We measured which engagement strategies most effectively drove individuals to get vaccinated. Follow-up surveys were sent to participants to identify those who reported vaccinations.
Results
Up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging.
Identified messages, content, and other tactics that most effectively drive high-risk individuals to schedule vaccinations.
The pharmaceutical team received data-driven insights to expand vaccination programs on a larger scale.
Increasing treatment rates with co-created patient engagement
Evidation and the Duke Big Ideas Lab have announced a partnership that aims to find ways to both increase representation of underserved populations and improve adherence among all participants in digital health studies.
The organizations are working together to build an analytic structure that will be available to other digital health researchers, helping to better predict study participation, adherence, and retention. Click below to read more about the project, led by Iredia M. Olaye, PhD, MSc, MHA, of Covered By Group and Evidation, in HealthLeaders.
Thanks to everyone who took the time to meet with us in San Francisco at this year’s J.P. Morgan Annual Conference and its surrounding events. Our team looks forward to staying in touch and helping you produce better health outcomes in 2023!
Get to know your Evidation team
Bertina Yen, Evidation's Senior Vice President of People & Community
Bertina Yen is Evidation's Senior Vice President of People & Community, where she is responsible for the end-to-end employee experience and building a community that supports everyone's ability to show up as their authentic selves and perform their best work. Prior to joining Evidation, Bertina served as EVP overseeing clinical teams, product management, marketing, and product development at Zynx Health, driving development of evidence-based clinical decision support solutions that improve health and financial outcomes.
Bertina received her BAS from Stanford, then completed her MD and residency in internal medicine at UC San Diego. She also holds an MPH in health services administration from UCLA.
Bertina is the resident DJ at Evidation and sources the music that is played during the All-Employee Meetings. Outside of work, she enjoys hiking, traveling, and watching anything with a live audience (sporting events, plays, movies). She also starts every morning by completing at least one crossword puzzle!
Increasing treatment rates with co-created patient engagement
Challenge
Evaluating the effectiveness of using digital interventions to increase flu vaccination rates among individuals with type 2 diabetes—a demographic at high risk for flu complications, yet comparatively low vaccination rates.
Approach
We rapidly recruited over 10,400 Evidation community members to a digital program providing vaccination education; ~50% were individuals with self-reported type 1 or 2 diabetes.
Over six months, we engaged participants through ads, educational content, incentives, surveys, and calls to action. As part of the message testing, different participant segments received a mix of content that promoted flu vaccinations more generally and content that focused on diabetes and the flu (e.g., risks specific to diabetes management), while some participants received no flu content at all.
We measured which engagement strategies most effectively drove individuals to get vaccinated. Follow-up surveys were sent to participants to identify those who reported vaccinations.
Results
Up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging.
Identified messages, content, and other tactics that most effectively drive high-risk individuals to schedule vaccinations.
The pharmaceutical team received data-driven insights to expand vaccination programs on a larger scale.
Evaluating the effectiveness of using digital interventions to increase flu vaccination rates among individuals with type 2 diabetes—a demographic at high risk for flu complications, yet comparatively low vaccination rates.
Approach
We rapidly recruited over 10,400 Evidation community members to a digital program providing vaccination education; ~50% were individuals with self-reported type 1 or 2 diabetes.
Over six months, we engaged participants through ads, educational content, incentives, surveys, and calls to action. As part of the message testing, different participant segments received a mix of content that promoted flu vaccinations more generally and content that focused on diabetes and the flu (e.g., risks specific to diabetes management), while some participants received no flu content at all.
We measured which engagement strategies most effectively drove individuals to get vaccinated. Follow-up surveys were sent to participants to identify those who reported vaccinations.
Results
Up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging.
Identified messages, content, and other tactics that most effectively drive high-risk individuals to schedule vaccinations.
The pharmaceutical team received data-driven insights to expand vaccination programs on a larger scale.
